Get more information on Infection Surveillance Solutions Market - Request Sample Report
The Infection Surveillance Solutions Market was valued at USD 650.16 million in 2023 and is expected to reach USD 2010.88 million by 2032, growing at a CAGR of 13.39% over the forecast period 2024-2032.
The Infection Surveillance Solutions market is witnessing robust growth, fueled by the increasing prevalence of healthcare-associated infections (HAIs) and the need for efficient infection prevention measures in healthcare facilities. According to the CDC, approximately one in 31 hospitalized patients in the U.S. contracts an HAI daily, leading to severe patient safety concerns, extended hospital stays, and higher healthcare costs. Globally, the WHO reports that 7% of patients in high-income countries and 15% in low- and middle-income countries are affected by at least one HAI during their hospital stay.
These infections contribute to significant healthcare burdens, with studies showing that infection surveillance systems can reduce HAI rates by up to 30% when integrated with electronic health records (EHRs). Moreover, the implementation of advanced technologies, such as AI-driven analytics and machine learning algorithms, has enhanced the capabilities of infection surveillance tools. These advancements enable real-time data analysis, early detection of potential outbreaks, and better resource allocation, empowering healthcare providers to act swiftly.
Regulatory bodies such as the WHO, CDC, and Joint Commission continue to emphasize the importance of infection prevention and control (IPC) programs. A recent WHO report highlights that well-implemented IPC strategies can lower infection rates by up to 70%, especially in under-resourced settings. These mandates have encouraged the adoption of surveillance solutions across hospitals, long-term care facilities, and outpatient clinics. Additionally, the growing integration of digital technologies, including cloud-based platforms, has expanded the accessibility and scalability of these systems. Research underscores their effectiveness in improving patient outcomes and reducing operational costs, making them a critical component of modern healthcare strategies.
As awareness about HAIs increases and healthcare facilities prioritize infection prevention, the market for infection surveillance solutions is expected to grow steadily. This growth reflects the global commitment to enhancing patient safety and combating the persistent challenge of infections in healthcare environments.
Drivers
The Infection Surveillance Solutions market is driven by several key factors, including the growing emphasis on improving patient safety and enhancing healthcare quality.
One significant driver is the increasing awareness among healthcare providers about the importance of preventing healthcare-associated infections (HAIs). With rising scrutiny from regulatory bodies and a greater focus on patient outcomes, hospitals and healthcare systems are prioritizing infection control measures to reduce complications, avoid penalties, and improve public trust.
Another driver is the rapid advancements in healthcare technologies, which have led to the development of more sophisticated and efficient infection surveillance solutions. The integration of artificial intelligence (AI) and machine learning allows for enhanced data analytics, enabling real-time infection tracking, early detection, and predictive insights. This technological progress is critical in managing the complex nature of infections, especially in large healthcare facilities.
The increasing adoption of electronic health records (EHRs) and digital health technologies has also contributed to market growth. These systems facilitate seamless integration with infection surveillance tools, allowing healthcare providers to access real-time data and improve coordination across departments. Moreover, the rising prevalence of chronic diseases and the aging population, which are associated with higher risks of infection, are further accelerating the demand for infection surveillance solutions.
Restraints
High Implementation Costs
The adoption of advanced infection surveillance solutions often requires significant upfront investments in technology, infrastructure, and training, which may limit the affordability for smaller healthcare facilities or those in developing regions.
Data Privacy and Security Concerns
The integration of digital technologies and cloud-based platforms raises concerns about the security and confidentiality of patient data, potentially hindering the adoption of infection surveillance systems due to regulatory and privacy issues.
By Component
In 2023, the Software segment was the dominant force in the Infection Surveillance Solutions market, accounting for the largest share. Software solutions provide healthcare institutions with essential tools for real-time data analysis, automated reporting, and infection monitoring, making them a crucial part of infection prevention and control efforts. The growing need for automation, real-time tracking, and data-driven insights has driven the adoption of these solutions. Software's dominance, making up around 70.0% of the market in 2023, can be attributed to its ability to integrate seamlessly with electronic health records (EHRs) and other healthcare management systems, improving operational efficiency and patient safety.
The Services segment emerged as the fastest-growing component in the market. This growth is fueled by the increasing demand for consulting, implementation, and support services that help healthcare facilities effectively integrate and optimize their infection surveillance systems. As infection control becomes more complex and technology-driven, hospitals and healthcare providers are seeking expert guidance on system deployment, maintenance, and performance optimization. Additionally, services like data analytics, training, and risk assessment are becoming crucial for tailoring solutions to specific healthcare environments, further boosting the segment's expansion.
By End-use
In 2023, Hospitals were the largest end-user segment, representing a significant portion of the infection surveillance solutions market. Hospitals are the primary setting for healthcare-associated infections (HAIs) and thus the largest consumers of infection surveillance systems. The need to reduce HAIs, comply with stringent regulatory requirements, and improve patient safety has led hospitals to prioritize the adoption of advanced infection surveillance technologies. Hospitals accounted for over 65.0% of the market share in 2023, reflecting their critical role in infection control efforts and the large-scale adoption of digital health solutions.
Long-Term Care Facilities (LTCFs) have emerged as the fastest-growing segment in the infection surveillance solutions market. With an aging population more vulnerable to infections, LTCFs are increasingly adopting infection surveillance solutions to enhance patient care and prevent outbreaks. The rising awareness of infection risks in long-term care settings and the growing focus on infection prevention and control within these facilities are driving their rapid adoption of surveillance technologies. This sector's growth is accelerating as LTCFs recognize the need for comprehensive infection monitoring systems to safeguard their residents' health and comply with new healthcare regulations.
North America held the largest share of the market in 2023, primarily due to the well-established healthcare systems in the U.S. and Canada. The region is highly focused on infection prevention and control, driven by stringent regulations and increasing awareness of healthcare-associated infections (HAIs). The U.S. alone accounts for a significant portion of the global market, with hospitals and long-term care facilities investing heavily in advanced infection surveillance technologies. The adoption of electronic health records (EHRs) and integration with AI-driven surveillance tools are some of the key drivers of growth in North America.
In Europe, the market is also experiencing strong growth, fueled by similar healthcare challenges related to HAIs. The region benefits from robust healthcare systems and is seeing an increase in government initiatives aimed at improving infection control in hospitals and long-term care settings. Countries such as the UK, Germany, and France are leading the charge in adopting infection surveillance solutions, driven by regulatory mandates and an aging population.
The Asia-Pacific region is the fastest-growing market, with countries like China, India, and Japan showing rapid adoption of infection surveillance solutions. The increasing healthcare infrastructure, rising awareness about HAIs, and growing focus on improving patient safety are driving this growth. Additionally, the region's large population and healthcare challenges make infection prevention and control a top priority.
Need any customization research on Infection Surveillance Solutions Market - Enquiry Now
1. Becton, Dickinson and Company (BD)
BD Infectious Disease Diagnostic Solutions
BD Synapsys Infection Surveillance Solution
2. Premier, Inc.
Premier SafetyCheck
Premier Infection Control Solutions
UpToDate (Clinical Decision Support)
Wolters Kluwer Health Infection Control Solutions
Baxter Infection Prevention Solutions (e.g., SafeSource)
5. Cerner Corporation (Oracle)
Cerner Infection Surveillance and Analytics Solution
PowerChart Infection Prevention
6. Clinisys
Clinisys Lab Management & Infection Surveillance Solutions
7. GOJO Industries
PURELL Infection Prevention Solutions
GOJO Hand Hygiene Compliance Solutions
8. Merative (formerly Truven Health Analytics)
Merative Infection Surveillance Solutions
Truven Health Analytics
9. Truven Health Analytics
Infection Control and Surveillance Systems (part of Merative now)
10. Vigilanz Corporation
VigiLanz Infection Surveillance and Management Solutions
11. RL Datix Ltd
RLDatix Infection Control Solutions
RL Datix Safety Management Systems
12. Deb Group Ltd. (UK)
Deb Hand Hygiene Solutions
13. BioVigil Healthcare Systems
BioVigil Hand Hygiene Compliance Monitoring System
14. Vecna Technologies, Inc.
Vecna Infection Prevention Solutions
15. Ecolab
Ecolab Infection Prevention and Control Solutions
Ecolab Hygiene Solutions for Healthcare
16. Harris Healthcare
Harris Infection Prevention Technologies
17. PeraHealth
PeraHealth Infection Surveillance Solutions
18. Medexter Healthcare
Medexter Infection Surveillance System
19. CenTrak, Inc.
CenTrak Infection Prevention and Control Solutions
20. bioMerieux SA
bioMerieux Infectious Disease Testing Solutions
VITEK 2 System for Infection Surveillance
21. CKM Healthcare
CKM Infection Control Solutions
22. Asolva Inc.
Asolva Infection Control Management System
23. PointClickCare
PointClickCare Infection Surveillance Solutions
24. STANLEY Healthcare
STANLEY Healthcare Infection Prevention Solutions
25. Vitalacy Inc.
Vitalacy Infection Control Solutions
26. VIZZIA Technologies
VIZZIA Infection Prevention Solutions
Recent Development
In June 2024, Becton, Dickinson, and Company (BD) announced its acquisition of Edwards Lifesciences' Critical Care Product Group for USD 4.2 billion. This strategic move aims to expand BD's smart connected care solutions and strengthen its position as a leader in advanced monitoring technologies, unlocking new growth opportunities in the critical care space.
In May 2024, Premier Inc. declared its partnership with AstraZeneca to leverage real-world data, AI-driven technologies, and scalable solutions to improve health outcomes and provide cost-effective solutions for patients.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 650.16 million |
| Market Size by 2032 | USD 2010.88 million |
| CAGR | CAGR of 13.39% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Component (Software, Services) • By End-use (Hospitals, Long-Term Care Facilities, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Becton, Dickinson and Company, Premier, Inc., Wolters Kluwer N.V., Baxter International Inc., Cerner Corporation (Oracle), Clinisys, GOJO Industries, Merative, Truven Health Analytics, Vigilanz Corporation, RL Datix Ltd, Deb Group Ltd., BioVigil Healthcare Systems, Vecna Technologies, Inc., Ecolab, Harris Healthcare, PeraHealth, Medexter Healthcare, CenTrak, Inc., bioMerieux SA, CKM Healthcare, Asolva Inc., PointClickCare, STANLEY Healthcare, Vitalacy Inc., VIZZIA Technologies. |
| Key Drivers | • The Infection Surveillance Solutions market is driven by several key factors, including the growing emphasis on improving patient safety and enhancing healthcare quality. |
| Restraints | • High Implementation Costs • Data Privacy and Security Concerns |
Ans: The market was valued at USD 650.16 million in 2023 and is expected to reach USD 2010.88 million by 2032, growing at a CAGR of 13.39% during the forecast period.
Ans: The Infection Surveillance Solutions Market is growing at a CAGR of 13.39% over the forecast period 2024-2032.
Ans: Major driving factors of Infection Surveillance Solutions Market are increased prevalence of healthcare-associated infections, technological advancements, regulatory mandates and aging population and chronic diseases.
Ans: Software: Accounts for approximately 70% of the market share due to real-time analytics, automated reporting, and integration with EHRs.
Services: The fastest-growing segment, driven by consulting, implementation, and support services tailored to healthcare settings.
Ans:
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Healthcare-Associated Infections (HAIs)
5.2 Growth and Adoption Trends (2023) by Region
5.3 Technology Adoption by Healthcare Facilities
5.4 Regulatory and Compliance Trends
5.5 Healthcare Spending Trends by Region
5.6 Technological Innovation and R&D Investment Trends
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Infection Surveillance Solutions Market Segmentation, by Component
7.2 Software
7.2.1 Software Market Trends Analysis (2020-2032)
7.2.2 Software Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Services
7.3.1 Services Market Trends Analysis (2020-2032)
7.3.2 Services Market Size Estimates and Forecasts to 2032 (USD Million)
8. Infection Surveillance Solutions Market Segmentation, by End-use
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Long Term Care Facilities
8.3.1 Long-Term Care Facilities Market Trends Analysis (2020-2032)
8.3.2 Long-Term Care Facilities Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Infection Surveillance Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.2.3 North America Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.2.4 North America Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.2.5 USA
9.2.5.1 USA Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.2.5.2 USA Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.2.6 Canada
9.2.6.1 Canada Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.2.6.2 Canada Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.2.7 Mexico
9.2.7.1 Mexico Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.2.7.2 Mexico Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Infection Surveillance Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.1.3 Eastern Europe Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.1.4 Eastern Europe Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.1.5 Poland
9.3.1.5.1 Poland Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.1.5.2 Poland Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.1.6 Romania
9.3.1.6.1 Romania Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.1.6.2 Romania Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.1.7.2 Hungary Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.1.8.2 Turkey Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.1.9.2 Rest of Eastern Europe Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Infection Surveillance Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.2.3 Western Europe Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.4 Western Europe Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2.5 Germany
9.3.2.5.1 Germany Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.5.2 Germany Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2.6 France
9.3.2.6.1 France Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.6.2 France Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2.7 UK
9.3.2.7.1 UK Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.7.2 UK Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2.8 Italy
9.3.2.8.1 Italy Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.8.2 Italy Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2.9 Spain
9.3.2.9.1 Spain Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.9.2 Spain Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.10.2 Netherlands Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.11.2 Switzerland Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2.12 Austria
9.3.2.12.1 Austria Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.12.2 Austria Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.3.2.13.2 Rest of Western Europe Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Infection Surveillance Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.4.3 Asia Pacific Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.4.4 Asia Pacific Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.4.5 China
9.4.5.1 China Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.4.5.2 China Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.4.6 India
9.4.5.1 India Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.4.5.2 India Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.4.5 Japan
9.4.5.1 Japan Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.4.5.2 Japan Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.4.6.2 South Korea Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.4.7 Vietnam
9.4.7.1 Vietnam Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.2.7.2 Vietnam Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.4.8 Singapore
9.4.8.1 Singapore Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.4.8.2 Singapore Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.4.9 Australia
9.4.9.1 Australia Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.4.9.2 Australia Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.4.10.2 Rest of Asia Pacific Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Infection Surveillance Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.1.3 Middle East Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.5.1.4 Middle East Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.5.1.5 UAE
9.5.1.5.1 UAE Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.5.1.5.2 UAE Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.5.1.6.2 Egypt Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.5.1.7.2 Saudi Arabia Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.5.1.8.2 Qatar Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.5.1.9.2 Rest of Middle East Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Infection Surveillance Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.2.3 Africa Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.5.2.4 Africa Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.5.2.5.2 South Africa Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.5.2.6.2 Nigeria Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Infection Surveillance Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.6.3 Latin America Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.6.4 Latin America Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.6.5 Brazil
9.6.5.1 Brazil Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.6.5.2 Brazil Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.6.6 Argentina
9.6.6.1 Argentina Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.6.6.2 Argentina Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.6.7 Colombia
9.6.7.1 Colombia Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.6.7.2 Colombia Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Infection Surveillance Solutions Market Estimates and Forecasts, by Component (2020-2032) (USD Million)
9.6.8.2 Rest of Latin America Infection Surveillance Solutions Market Estimates and Forecasts, by End-use (2020-2032) (USD Million)
10. Company Profiles
10.1 Becton, Dickinson, and Company
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Premier, Inc.
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Wolters Kluwer N.V.
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Cerner Corporation (Oracle)
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Baxter International Inc.
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Truven Health Analytics
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Vigilanz Corporation
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 BioVigil Healthcare Systems
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Ecolab
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Harris Healthcare
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Software
Services
By End-use
Hospitals
Long Term Care Facilities
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Single-cell Omics Market size was estimated at USD 1.61 billion in 2023 and is expected to reach USD 6.21 billion by 2032 with a growing CAGR of 16.2% during the forecast period of 2024-2032.
The Dental Suction Systems Market Size was valued at USD 516.08 Million in 2023 and is expected to reach USD 800.30 Million by 2032 and grow at a CAGR of 5.18% Over the forecast period of 2024-2032.
The Specialty PACS Market Size was valued at USD 3.3 billion in 2023, and expected to reach USD 5.29 billion by 2031, and grow at a CAGR of 6.1% over the forecast period 2024-2031.
The Healthcare Education Market Size was valued at USD 107 billion in 2023, & is will reach USD 225 billion by 2032 and grow at a CAGR of 8.6% by 2024-2032.
The Medical Ceramics Market Size was valued at USD 20.2 billion in 2023, and is expected to reach USD 31.63 billion by 2032, and grow at a CAGR of 5.11% over the forecast period 2024-2032.
The Active Pharmaceutical Ingredient Market was valued at USD 239.45 billion in 2023 and is projected to reach USD 371.06 billion by 2032 and grow at a CAGR of 5.37% from 2024 to 2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
